【レポートの概要(一部)】
1 Table of Contents
1 Table of Contents 5
1.1 List of Tables 8
1.2 List of Figures 9
2 Introduction 10
3 Therapeutic Landscape 11
3.1 Heart Failure 11
3.1.1 Symptoms 11
3.1.2 Etiology 12
3.1.3 Pathophysiology 12
3.1.4 Co-morbidities and Complications 12
3.1.5 Diagnosis 13
3.1.6 Classification 14
3.1.7 Prognosis and Disease Staging 14
3.1.8 Treatment Options 15
3.2 Myocardial Infarction 18
3.2.1 Symptoms 18
3.2.2 Etiology 18
3.2.3 Pathophysiology 18
3.2.4 Co-morbidities and Complications 19
3.2.5 Diagnosis 19
3.2.6 Classification 20
3.2.7 Treatment Options 21
3.3 Acute Coronary Syndrome 22
3.3.1 Symptoms 22
3.3.2 Etiology 22
3.3.3 Pathophysiology 23
3.3.4 Diagnosis 23
3.3.5 Treatment Options 24
4 Marketed Products 27
4.1 Heart Failure 27
4.2 Myocardial Infarction 27
4.3 Acute Coronary Syndrome 27
4.4 Key Marketed Products 27
4.4.1 Arixtra 27
4.4.2 Brilinta 29
4.4.3 Crestor 30
4.4.4 Diovan and Diovan HCT/Co-Diovan 31
4.4.5 Atacand 31
4.4.6 Lipitor 32
4.4.7 Clopidogrel bisulfate 33
4.4.8 Angiomax 33
4.4.9 Lovenox 34
4.4.10 Norvasc 35
4.4.11 Coreg 35
4.4.12 Ivabradine 37
4.4.13 Toprol-XL 37
5 Pipeline Analysis 39
5.1 Heart Failure Pipeline 39
5.1.1 Overall Pipeline 39
5.1.2 Pipeline Analysis by Molecule Type 40
5.1.3 Pipeline Analysis by Mechanism of Action 41
5.2 Myocardial Infarction Pipeline 42
5.2.1 Overall Pipeline 42
5.2.2 Pipeline Analysis by Molecule Type 43
5.2.3 Pipeline Analysis by Mechanism of Action 44
5.3 Acute Coronary Syndrome Pipeline 45
5.3.1 Overall Pipeline 45
5.3.2 Pipeline Analysis by Molecule Type 46
5.3.3 Pipeline Analysis by Mechanism of Action 47
5.4 Promising Drug Candidates in the Pipeline 48
5.4.1 LCZ-696 48
5.4.2 Darapladib (SB-480848) 49
5.4.3 Neucardin 50
5.4.4 Cangrelor 51
5.4.5 Serelaxin (Novartis AG) 51
6 Cardiovascular Diseases Global Market to 2019, Market Forecast 52
6.1 Global Market 52
6.1.1 Treatment Usage Patterns 52
6.1.2 Annual Cost of Treatment 52
6.1.3 Market Size 52
6.2 US 54
6.2.1 Treatment Usage Patterns 54
6.2.2 Annual Cost of Treatment 54
6.2.3 Market Size 54
6.3 France 56
6.3.1 Treatment Usage Patterns 56
6.3.2 Annual Cost of Treatment 56
6.3.3 Market Size 56
6.4 Spain 58
6.4.1 Treatment Usage Patterns 58
6.4.2 Annual Cost of Treatment 58
6.4.3 Market Size 58
6.5 Germany 60
6.5.1 Treatment Usage Patterns 60
6.5.2 Annual Cost of Treatment 60
6.5.3 Market Size 60
6.6 Italy 62
6.6.1 Treatment Usage Patterns 62
6.6.2 Annual Cost of Treatment 62
6.6.3 Market Size 62
6.7 UK 64
6.7.1 Treatment Usage Patterns 64
6.7.2 Annual Cost of Treatment 64
6.7.3 Market Size 64
6.8 Japan 66
6.8.1 Treatment Usage Patterns 66
6.8.2 Annual Cost of Therapy 66
6.8.3 Market Size 66
6.9 Canada 68
6.9.1 Treatment Usage Patterns 68
6.9.2 Annual Cost of Treatment 68
6.9.3 Market Size 68
6.10 Drivers and Barriers for the Global Cardiovascular Diseases Market 70
6.10.1 Drivers 70
6.10.2 Barriers 70
7 Deals and Strategic Consolidations 71
7.1 Deals Analysis 71
7.2 Major Co-development Deals 73
7.2.1 Genzyme Enters into Agreement with Osiris Therapeutics 74
7.2.2 Les Laboratoires Servier Enters into Co-development Agreement with miRagen Therapeutics 74
7.2.3 Cytokinetics Signs Strategic Agreement with Amgen 74
7.2.4 Biogen Idec Inc. Enters into Agreement with Cardiokine Inc. 74
7.2.5 Bristol-Myers Squibb Enters into Co-Development Agreement with Ambrx Inc. 75
7.2.6 Angioblast Systems Inc. Enters into Co-Development Agreement with Abbott India Limited 75
7.3 Major Licensing Deals 76
7.3.1 Cephalon Inc. Enters into Licensing Agreement with Mesoblast Limited for Regenerative Medicine 77
7.3.2 The Medicines Company Enters into Licensing Agreement with Pfizer Inc. 77
7.3.3 BioLineRx, Ltd. Enters into Licensing Agreement With Ikaria Holdings, Inc. 77
7.3.4 KAI Pharmaceuticals, Inc. Enters into Licensing Agreement with Bristol-Myers Squibb 77
7.3.5 Theravance, Inc. Enters into Licensing Agreement with Merck & Co., Inc. for Cardiovascular Therapeutic Candidates 78
7.3.6 Novartis AG Enters into License Agreement with Portola Pharmaceuticals, Inc. 79
7.3.7 Salix Pharmaceuticals, Ltd. Enters into License Agreement with Merck & Co, Inc. 79
7.3.8 Amgen Enters into Licensing Agreement with Cytokinetics 79
8 Appendix 80
8.1 Market Definitions 80
8.2 Abbreviations 80
8.3 Sources 82
8.4 All Pipeline Drugs by Phase 84
8.4.1 Preclinical 84
8.4.2 Pre-registration 87
8.4.3 Phase I 88
8.4.4 Phase II 89
8.4.5 Phase III 91
8.4.6 Discontinued 92
8.4.7 Filing rejected/Withdrawn 93
8.5 Market Forecasts to 2019 93
8.5.1 Global 93
8.5.2 US 94
8.5.3 UK 95
8.5.4 France 96
8.5.5 Spain 97
8.5.6 Germany 98
8.5.7 Italy 99
8.5.8 Japan 100
8.5.9 Canada 101
8.6 Research Methodology 102
8.6.1 Coverage 102
8.6.2 Secondary Research 102
8.6.3 Primary Research 103
8.6.4 Therapeutic Landscape 103
8.6.5 Geographical Landscape 106
8.6.6 Pipeline Analysis 106
8.7 Expert Panel Validation 106
8.8 Contact Us 106
8.9 Disclaimer 106
【レポート販売概要】
■ タイトル:Cardiovascular Diseases Therapeutics in Major Developed Markets to 2019 – Increasing Prevalence and Promising Novel Drugs offset Patent Cliff Threat■ 発行日:2013年11月30日
■ 調査会社:GBI Research
■ 商品コード:GBIR403170046
■ 調査対象地域:グローバル
- グルホシネートの世界市場:作物種類別(シリアル&穀物、油料種子&豆類、果物&野菜、その他)、製剤種類別(水性懸濁液、液体、懸濁液濃縮物、可溶性(液体)濃縮物、その他)The global glufosinate market was valued at $544.8 million in 2018, and is projected to reach $2,097.7 million by 2026, growing at a CAGR of 19.0% from 2019 to 2026. Glufosinate is a naturally occurring herbicide isolated from two species of Streptomyces fungi. It is widely used as a substitute of glyphosate and paraquat and is used to control a wide range of weeds such as morning glories, hemp se …
- 紫外線(UV)分析装置の世界市場予測(~2024年)“Ultraviolet analyzer market to grow at a CAGR of 6.4% from 2019 to 2024”The ultraviolet analyzer market is expected to grow from USD 1.0 billion by 2019 to USD 1.4 billion by 2024 at a CAGR of 6.4% from 2019 to 2024. A few key factors driving the growth of this market include a rise in demand for environmental protection would upsurge the demand for ultraviolet analyzers for emission monitoring, …
- 2014年戦略提言:フランスの治療薬物モニタリング(TDM)市場This new 247-page report from Venture Planning Group provides a comprehensive analysis of the French therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carba …
- ICT調達動向:政府部門 – 企業のICT投資計画Why was the report written? To highlight the criteria on which government institutions select their ICT providers as well as the roles which have influence while making ICT purchasing decisions. What is the current market landscape and what is changing? Government institutions have an optimistic approach towards IT investments, and their preference towards hosted services is slowly gaining tractio …
- オートクレーブの世界市場2016-2020About Autoclave Autoclaves are used to sterilize diagnostic equipment, laboratory glassware, and surgical instruments by subjecting them to high-pressure steam at 249ºF for 15-20 minutes, based on the nature of the material inside. The use of an autoclave for sterilizing materials and for treating biomedical waste is fast, safe, and convenient. Autoclaves are commonly used in laboratories and medi …
- 手術室管理ソリューションの世界市場:データ管理、麻酔情報管理、手術用イメージングシステム、パフォーマンス管理システム、記録ツール等Need for Patient Safety, Increase in OR Efficiency, and Ageing Population Undergoing Large Number of Surgeries to Drive Growth of the ORM market Developing markets such as the Middle East, China, India, and Malaysia are lucrative markets for ORM systems, owing to favorable government incentives and developing healthcare IT infrastructure. This report segments the global ORM market by product, appl …
- スマートミラー(Smart Mirror)市場2013The objective of this report identifies and quantifies the opportunities, challenges, and prospects for growth of smart mirrors. Specifically, it analyzes the capabilities of current and likely future smart mirror technologies and how these technologies may be deployed in both automotive and non-automotive applications. Smart technologies covered in the report include the following: Self-dimming t …
- 電力測定器の世界市場:スマートメーター、デジタルメーター、アナログメーターThis report estimates the power metering market in terms of value in USD million and the number of units the meters shipped. This has been broken down into regions, and further split into countries. The construction industry along with an increase in the electrification rate in various countries across the globe to provide better living standards would help drive the power metering market. A power …
- PDMS(ポリジメチルシロキサン)の世界市場予測(~2024年)“Growing PDMS consumption in personal care, medical, automotive, construction industries is expected to drive the PDMS market.” The polydimethylsiloxane (PDMS) market size is estimated to be USD 4.0 billion in 2019 and is projected to reach USD 5.2 billion by 2024, at a CAGR of 6.0%. The increasing demand for PDMS from industries such as personal care, medical, automotive, construction and others …
- 発電機レンタルの世界市場:契約件数および取引分析Global power rental contracts and agreements grew by 26% in 2015. This growth is attributed to continued growth of constructional & developmental activities and increasing demand-supply gap of electric power in emerging economies. The report segments global power rental contracts and deals on the basis of its strategy, which include contracts and agreements, investments and expansions, mergers and …
- マイクロサーバーICの世界市場予測(~2022):プロセッサ別、提供形態別、需要先別、用途別(メディアストレージ、データセンター、クラウドコンピューティング)、地域別The micro server IC market is expected to be worth USD 1.35 Billion by 2022, at a CAGR of 44.0% between 2016 and 2022. Some of the key factors driving this market are low power consumption and space usage by micro servers, growing trend of cloud computing and web hosting, cost effectiveness of micro servers in comparison with traditional servers, and emerging hyperscale data center architecture. T …
- 農業用微量栄養素の世界市場:亜鉛、マンガン、ホウ素、銅、モリブデン、鉄The agricultural micronutrients market has grown exponentially in the last few years and this trend is projected to continue. The market was estimated at $4.8 billion in 2014 and is projected to grow at a CAGR of 8.1% from 2015 to 2020; the market is projected to reach $7.6 billion by 2020. The market is primarily driven by the increasing demand for food in tandem with the growing disposable incom …
- イランの水力発電市場2016:発電能力、生産、投資動向、制度、企業Hydropower in Iran, Market Outlook to 2030, Update 2016 - Capacity, Generation, Levelized Cost of Energy (LCOE), Investment Trends, Regulations and Company Profiles Summary "Hydropower in Iran, Market Outlook to 2030, Update 2016 - Capacity, Generation, Levelized Cost of Energy (LCOE), Investment Trends, Regulations and Company Profiles” is the latest report from GlobalData, the industry analysis …
- クラウドベース情報ガバナンスの世界市場2016-2020About Cloud-based Information Governance Information governance is the application of technologies, policies, and processes to maximize the value of information from inception to final disposal. It helps organization manage information risks, reduce information costs, and maximize business benefits. Information governance includes traditional records management, information security and protection …
- 遺伝子発現用器具/消耗品/サービスの世界市場About Gene Expression Gene expression is the biological process where genetic information is used for the synthesis of a functional gene product, either RNA or protein. Gene expression products allow researchers to study gene expression and its impact on cell function. Researchers use gene expression profiling and analysis for various applications in the areas of drug discovery and development, cl …